共沉淀法制备Y_2O_2S∶Eu~(3+),Mg~(2+),Ti~(4+)红色长余辉材料

用共沉淀法制备了Y2O2S∶Eu3 ,Mg2 ,Ti4 红色长余辉材料。测量了材料的电子显微形貌、晶体结构和发射光谱。通过与固相法制备的Y2O2S∶Eu3 ,Mg2 ,Ti4 长余辉材料比较,发现两种方法都可以制备粒度基本相同的纯相Y2O2S基质晶体,但共沉淀法样品的颗粒结构更松散。研究了Eu3 浓度对两种方法制备样品的谱线发射强度的影响,通过比较共沉淀法和高温固相法制备的样品中Eu3 的5D1→7F3较高能级跃迁的587.6 nm谱线强度随Eu3 浓度的变化,发现共沉淀法更有利于Eu3 均匀进入Y2O2S基质晶格而形成有效的发光中心。     

An Anti-Control Scheme for Spiral under Lorenz Chaotic Signals

The Fitzhugh-Nagumo (FHN) equation is used to generate spiral and spatiotemporal chaos. The weak Lorenz chaotic signal is imposed on the system locally and globally. It is found that for the right chaotic driving signal,spiral and spatiotemporal chaos can be suppressed. The simulation results also show that this anti-control scheme is effective so that the system emerges into the stable states quickly after a short duration of chaotic driving (about 50 time units) and the continuous driving keeps the system in a homogeneous state.     

基因组重排问题的一个近似算法

分子生物学中基因无方向的反向基因组重排问题在数学上已被证明是一个NP困难问题．基于断点图的概念，给出一个时间复杂性为O(max{b^(π)，nb(π)})，空间复杂性为0(n)的求其近似最优解的算法．其中n为基因组中基因个数，π=(π1,π2，…，πn)表示n个基因的一种排列，b(π)表示排列π中的断点数．数据实验的结果表明，该近似算法可以求得较好的结果．     

基于实数编码的免疫遗传算法研究

针对标准遗传算法(SGA)搜索效率低、收敛速度慢等缺陷，在免疫遗传算法的基础上提出了基于实数编码的免疫遗传算法(RIGA)。研究表明，RIGA对SGA的改进是有效可行的，显示出稳健的全局优化、计算量少而解的精度高等特点，具有较高的应用价值。     

免疫算法在车辆调度问题中的应用

免疫算法是模仿生物体高度进化、复杂的免疫系统仿生的一种智能化启发式算法。本文根据车辆调度问题的具体情况，应用免疫算法解决车辆调度中路线安排问题，并提出了一种基于分组匹配的亲和力的计算方法。实验结果表明，免疫算法能有效地应用于车辆调度中路线安排问题。     

一种pH敏感相分离高分子在免疫分析中的应用

将乙肝表面抗体与N-羟基琥珀酰亚胺丙烯酸酯反应，生成丙烯酰基抗体．丙烯酰基抗体与甲基丙烯酸、丙烯酰胺共聚，生成pH敏感的三元共聚物．三元共聚物溶解．沉淀的临界pH值为3．8．三元共聚物上的抗体能与表面抗原、酶标抗体形成夹心复合物．利用三元共聚物可逆的溶解．沉淀特性，能实现在均相条件下，进行免疫反应，在异相条件下，进行免疫复合物的分离．     

用反向调制照明法分析光栅成像效应

提出了用反向调制照法明分析光栅成像效应的观点，研究了光栅系统的反向衍射干涉效应，成功地揭示了泰伯效应与劳效应的内在联系，并在白光双光栅衍射干涉的“消色效应”的基础上获得了白光扩展光源照明下白光光栅成像效应和具有实用意义的四光栅干涉系统。     

用计算机测量PN结的反向物理特性

本对PN结反向物理特性，应用电子技术和计算机技术实现了对实验过程的控制和效据处理。     

Effect of Notoginsenoside-Rg1 on the Expression of Several Proteins in the Striatum of Rat Models with Parkinson＇s Disease

After establishing hemi-Parkinsonian rat models, the relationships between neuron death and the expression of several proteins, such as c-Fos, GFAP, GDNF, NF-κB and some cytokines were determined. Therapeutics experiments with notoginsenoside-Rg1 were carried out. The research results show that the expressions of GFAP, NF-Kκ and c-Fos will obviously increase in the lesion side of the striatum and the expression of GDNF will decrease, which implies that the signal transduction pathway may participate in the apoptosis in neurons. The levels of some cytokines such as TNF-α, IL-1β in the striatum of PD rat models increased compared to those of normal rats. The results of the therapeutics experiments show that notoginsenoside-Rg1 may repress the immune inflammation response and regulate the immune function through the neuro-immune molecular network. Therefore, notoginsenoside-Rg1 can be used as an effective drug for anti-oxidation and anti-inflammation, and can be used in the therapy of Parkinson＇s disease（PD）.